A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations

Brian G. Blair, Xinyan Wu, Muhammad Saddiq Zahari, Morassa Mohseni, Justin Cidado, Hong Yuen Wong, Julia Beaver, Rory L. Cochran, Daniel J. Zabransky, Sarah Croessmann, David Chu, Patricia Valda Toro, Karen Cravero, Akhilesh Pandey, Ben Ho Park

Research output: Contribution to journalArticle

Abstract

The PIK3CA gene encodes for the p110 alpha isoform of PI3 kinase and is one of the most frequently mutated oncogenes in human cancers. However, the mechanisms by which PIK3CA mutations activate cell signaling are not fully understood. Here we used a phosphoproteomic approach to compare differential phosphorylation patterns between human breast epithelial cells and two isogenic somatic cell knock in derivatives, each harboring a distinct PIK3CA mutation. We demonstrated differential phosphorylation patterns between isogenic cell lines containing a PIK3CA helical domain mutation (E545K) compared to cells with a PIK3CA kinase domain mutation (H1047R). In particular, the receptor tyrosine kinase, HER3, showed increased phosphorylation at tyrosine 1328 in H1047R cells versus E545K cells. Genetic studies using shRNA demonstrated that H1047R cells have a profound decrease in growth factor independent proliferation upon HER3 knock down, but this effect was attenuated in E545K cells. In addition, HER3 knock down led to reductions in both PI3 kinase and MAP kinase pathway activation in H1047R cells, but in E545K cells only PI3 kinase pathway diminution was observed. These studies demonstrate the power of using paired isogenic cell lines for proteomic analysis to gain new insights into oncogenic signal transduction pathways.

Original languageEnglish (US)
Pages (from-to)318-326
Number of pages9
JournalProteomics
Volume15
Issue number2-3
DOIs
StatePublished - Jan 1 2015

Fingerprint

Phosphorylation
Phosphatidylinositol 3-Kinases
Phosphotransferases
Chemical activation
Mutation
Cells
Cell signaling
Signal transduction
Mitogen-Activated Protein Kinase Kinases
Receptor Protein-Tyrosine Kinases
Small Interfering RNA
Tyrosine
Intercellular Signaling Peptides and Proteins
Protein Isoforms
Genes
Derivatives
Cell Line
Oncogenes
Proteomics
Signal Transduction

Keywords

  • Biomedicine
  • HER3
  • MAP kinase
  • PI3 kinase
  • PIK3CA

ASJC Scopus subject areas

  • Molecular Biology
  • Biochemistry

Cite this

Blair, B. G., Wu, X., Zahari, M. S., Mohseni, M., Cidado, J., Wong, H. Y., ... Park, B. H. (2015). A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations. Proteomics, 15(2-3), 318-326. https://doi.org/10.1002/pmic.201400342

A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations. / Blair, Brian G.; Wu, Xinyan; Zahari, Muhammad Saddiq; Mohseni, Morassa; Cidado, Justin; Wong, Hong Yuen; Beaver, Julia; Cochran, Rory L.; Zabransky, Daniel J.; Croessmann, Sarah; Chu, David; Toro, Patricia Valda; Cravero, Karen; Pandey, Akhilesh; Park, Ben Ho.

In: Proteomics, Vol. 15, No. 2-3, 01.01.2015, p. 318-326.

Research output: Contribution to journalArticle

Blair, BG, Wu, X, Zahari, MS, Mohseni, M, Cidado, J, Wong, HY, Beaver, J, Cochran, RL, Zabransky, DJ, Croessmann, S, Chu, D, Toro, PV, Cravero, K, Pandey, A & Park, BH 2015, 'A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations', Proteomics, vol. 15, no. 2-3, pp. 318-326. https://doi.org/10.1002/pmic.201400342
Blair, Brian G. ; Wu, Xinyan ; Zahari, Muhammad Saddiq ; Mohseni, Morassa ; Cidado, Justin ; Wong, Hong Yuen ; Beaver, Julia ; Cochran, Rory L. ; Zabransky, Daniel J. ; Croessmann, Sarah ; Chu, David ; Toro, Patricia Valda ; Cravero, Karen ; Pandey, Akhilesh ; Park, Ben Ho. / A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations. In: Proteomics. 2015 ; Vol. 15, No. 2-3. pp. 318-326.
@article{c62667b2679c43f4a990c7746fb792f3,
title = "A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations",
abstract = "The PIK3CA gene encodes for the p110 alpha isoform of PI3 kinase and is one of the most frequently mutated oncogenes in human cancers. However, the mechanisms by which PIK3CA mutations activate cell signaling are not fully understood. Here we used a phosphoproteomic approach to compare differential phosphorylation patterns between human breast epithelial cells and two isogenic somatic cell knock in derivatives, each harboring a distinct PIK3CA mutation. We demonstrated differential phosphorylation patterns between isogenic cell lines containing a PIK3CA helical domain mutation (E545K) compared to cells with a PIK3CA kinase domain mutation (H1047R). In particular, the receptor tyrosine kinase, HER3, showed increased phosphorylation at tyrosine 1328 in H1047R cells versus E545K cells. Genetic studies using shRNA demonstrated that H1047R cells have a profound decrease in growth factor independent proliferation upon HER3 knock down, but this effect was attenuated in E545K cells. In addition, HER3 knock down led to reductions in both PI3 kinase and MAP kinase pathway activation in H1047R cells, but in E545K cells only PI3 kinase pathway diminution was observed. These studies demonstrate the power of using paired isogenic cell lines for proteomic analysis to gain new insights into oncogenic signal transduction pathways.",
keywords = "Biomedicine, HER3, MAP kinase, PI3 kinase, PIK3CA",
author = "Blair, {Brian G.} and Xinyan Wu and Zahari, {Muhammad Saddiq} and Morassa Mohseni and Justin Cidado and Wong, {Hong Yuen} and Julia Beaver and Cochran, {Rory L.} and Zabransky, {Daniel J.} and Sarah Croessmann and David Chu and Toro, {Patricia Valda} and Karen Cravero and Akhilesh Pandey and Park, {Ben Ho}",
year = "2015",
month = "1",
day = "1",
doi = "10.1002/pmic.201400342",
language = "English (US)",
volume = "15",
pages = "318--326",
journal = "Proteomics",
issn = "1615-9853",
publisher = "Wiley-VCH Verlag",
number = "2-3",

}

TY - JOUR

T1 - A phosphoproteomic screen demonstrates differential dependence on HER3 for MAP kinase pathway activation by distinct PIK3CA mutations

AU - Blair, Brian G.

AU - Wu, Xinyan

AU - Zahari, Muhammad Saddiq

AU - Mohseni, Morassa

AU - Cidado, Justin

AU - Wong, Hong Yuen

AU - Beaver, Julia

AU - Cochran, Rory L.

AU - Zabransky, Daniel J.

AU - Croessmann, Sarah

AU - Chu, David

AU - Toro, Patricia Valda

AU - Cravero, Karen

AU - Pandey, Akhilesh

AU - Park, Ben Ho

PY - 2015/1/1

Y1 - 2015/1/1

N2 - The PIK3CA gene encodes for the p110 alpha isoform of PI3 kinase and is one of the most frequently mutated oncogenes in human cancers. However, the mechanisms by which PIK3CA mutations activate cell signaling are not fully understood. Here we used a phosphoproteomic approach to compare differential phosphorylation patterns between human breast epithelial cells and two isogenic somatic cell knock in derivatives, each harboring a distinct PIK3CA mutation. We demonstrated differential phosphorylation patterns between isogenic cell lines containing a PIK3CA helical domain mutation (E545K) compared to cells with a PIK3CA kinase domain mutation (H1047R). In particular, the receptor tyrosine kinase, HER3, showed increased phosphorylation at tyrosine 1328 in H1047R cells versus E545K cells. Genetic studies using shRNA demonstrated that H1047R cells have a profound decrease in growth factor independent proliferation upon HER3 knock down, but this effect was attenuated in E545K cells. In addition, HER3 knock down led to reductions in both PI3 kinase and MAP kinase pathway activation in H1047R cells, but in E545K cells only PI3 kinase pathway diminution was observed. These studies demonstrate the power of using paired isogenic cell lines for proteomic analysis to gain new insights into oncogenic signal transduction pathways.

AB - The PIK3CA gene encodes for the p110 alpha isoform of PI3 kinase and is one of the most frequently mutated oncogenes in human cancers. However, the mechanisms by which PIK3CA mutations activate cell signaling are not fully understood. Here we used a phosphoproteomic approach to compare differential phosphorylation patterns between human breast epithelial cells and two isogenic somatic cell knock in derivatives, each harboring a distinct PIK3CA mutation. We demonstrated differential phosphorylation patterns between isogenic cell lines containing a PIK3CA helical domain mutation (E545K) compared to cells with a PIK3CA kinase domain mutation (H1047R). In particular, the receptor tyrosine kinase, HER3, showed increased phosphorylation at tyrosine 1328 in H1047R cells versus E545K cells. Genetic studies using shRNA demonstrated that H1047R cells have a profound decrease in growth factor independent proliferation upon HER3 knock down, but this effect was attenuated in E545K cells. In addition, HER3 knock down led to reductions in both PI3 kinase and MAP kinase pathway activation in H1047R cells, but in E545K cells only PI3 kinase pathway diminution was observed. These studies demonstrate the power of using paired isogenic cell lines for proteomic analysis to gain new insights into oncogenic signal transduction pathways.

KW - Biomedicine

KW - HER3

KW - MAP kinase

KW - PI3 kinase

KW - PIK3CA

UR - http://www.scopus.com/inward/record.url?scp=84921418516&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84921418516&partnerID=8YFLogxK

U2 - 10.1002/pmic.201400342

DO - 10.1002/pmic.201400342

M3 - Article

VL - 15

SP - 318

EP - 326

JO - Proteomics

JF - Proteomics

SN - 1615-9853

IS - 2-3

ER -